Navigation Links
Fair trade
Date:6/16/2008

This release is available in German.

Because of its toxicity and the dangers involved in handling it, tetrachloromethane (carbon tetrachloride, CCl4) can no longer be used or produced in many countries. However, the processes used in the production of other chlorinated hydrocarbons, such as chloroform (trichloromethane, CHCl3), also produce CCl4 as a byproduct. What is the best way to get rid of this unwanted substance? A team headed by Bert M. Weckhuysen at the University of Utrecht (Netherlands) has now found an interesting new approach that may lead to effective recycling. As the researchers report in the journal Angewandte Chemie, a lanthanum chloride catalyst induces CCl4 and its reaction partner dichloromethane (CH2Cl2) to exchange one chlorine atom for a hydrogen atom, forming nearly 100 % of the desired CHCl3.

In order to increase the catalyst surface, lanthanum chloride (LaCl3) was deposited onto carbon nanofiber supports. This results in a highly active, selective, and stable catalyst to facilitate the hydrogenchlorine exchange between CCl4 and CH2Cl2. "Computer calculations suggest," says Weckhuysen, "that the mechanism occurs by way of two separate hydrogenchlorine exchange reactions." It appears that the surface of the LaCl3 catalyst contains not only the terminal chlorine atoms of the crystal lattice, but also other weakly adsorbed species. CH2Cl2 swaps one of its hydrogen atoms for one such weakly bound chlorine atom. It leaves behind the hydrogen atom, which is in turn weakly adsorbed to the catalyst surface. This hydrogen atom can be taken up by CCl4, which in turn leaves one of its chlorine atoms behind on the catalyst surface. Both of these reaction steps produce chloroform exclusively; no byproducts come into play.

This new catalytic reaction is astonishing in that it was previously assumed that the presence of oxygeneither in the gas phase or bound to the crystal lattice of the catalystis required for such reactions. Says Weckhuysen: "We are reporting for the first time a lanthanum-based catalyst material that can activate both C-H and C-Cl bonds in the absence of oxygen." (2193 characters)


'/>"/>

Contact: Bert M. Weckhuysen
b.m.weckhuysen@uu.nl
31-302-534-328
Wiley-Blackwell
Source:Eurekalert  

Related biology news :

1. Stinger Systems To Offer Taser Trade-In Program
2. Global trade in tiger shrimp threatens environment
3. Markets of biodiversity and equity in trade: An illusion?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fair trade
(Date:3/8/2016)... 2016   Valencell , the leading innovator ... has secured $11M in Series D financing. The ... venture fund being launched by UAE-based financial services ... investors TDF Ventures and WSJ Joshua Fund. Valencell ... triple-digit growth and accelerate its pioneering innovation in ...
(Date:3/3/2016)... , March 3, 2016  2016FLEX, organized by ... week highlighting advancements in flexible, hybrid and printed ... setting attendance - have gathered for short courses, ... field of electronics. The Flex Conference celebrates its ... for companies, R&D organizations, and universities contributing to ...
(Date:3/2/2016)... March 2, 2016 ... addition of the  "Global Biometrics Market in ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , Global biometrics ... at a CAGR of around 27%   ... has announced the addition of the  "Global ...
Breaking Biology News(10 mins):
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... This June ... Tampa, Florida. As an exclusive sales and service provider of the ALPINION line, ... 2016 is the premier conference for healthcare technology management. The event draws more than ...
(Date:5/5/2016)... ... May 05, 2016 , ... ProMIS Neurosciences ... its first three targets, it has identified a fourth in a series of ... the development and progression of Alzheimer’s disease (AD). , “This discovery ...
(Date:5/4/2016)... , May 4, 2016  Bayer today announced ... compound Stivarga ® (regorafenib) tablets for the ... has met its primary endpoint of a statistically ... RESORCE, evaluated the efficacy and safety of regorafenib ... after treatment with sorafenib. The safety and tolerability ...
(Date:5/4/2016)... New York, NY (PRWEB) , ... May 04, ... ... growth, has leveraged recent innovations in biotechnology to help treat hormonal and stress ... hair loss, Nutrafol® has captured the hearts of key opinion leaders in the ...
Breaking Biology Technology: